论文信息 - Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib - 字舞流文

Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib

J. Engelman | A. Shaw | B. Yeap | F. de Marinis | B. Solomon | D. Tan | J. Gainor | Katherine R Schultz | L. Friboulet | G. Spitaleri | C. Lazzari | A. Ahmad | T. D. De Pas | Katherine R. Schultz